Lexicon Pharmaceuticals Inc at Evercore ISI HealthCONx Conference Transcript
(technical difficulty) Pharmaceuticals. In attendance today are Lonnel Coats, CEO; Jeff Wade, President and CFO; Craig Granowitz, Senior Vice President and CMO; and Tom Garner, SVP and CCO. Gentlemen, welcome. Thanks so much for coming down to Miami for our conference. Love to dig into it. Before we get into specifics, well, to kick it off with you guys maybe spend three to five minutes giving an overview on where Lexicon is going and perhaps maybe highlight some nuances that aren't well appreciated or well noticed by the Street.
I'll start if you don't mind. This is Lonnel.
A couple of things, one, is that it's such an awesome opportunity where we are right now. We have INPEFA that has now becoming well received in the marketplace as an important treatment option for heart failure, especially for those patients who are recently discharged or who are had a recent event. And so a very specific area because of a unique label that we have give us an opportunity to address those patients.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |